Early signs of survival benefit raise optimism around a small biotech's ALS drug

Early signs of survival benefit raise optimism around a small biotech's ALS drug

Source: 
BioPharma Dive
snippet: 

Patients with amyotrophic lateral sclerosis, a debilitating and fatal neurological disease, have few treatment options. The scarcity helps explain why an experimental drug attracted attention earlier this year, as a small study found its use appeared to slow functional decline in people with rapidly advancing ALS.